Mme POZET Astrid

Fiche personne

Coordonnées

CHRU Besançon
3 bd Fleming
25030 BESANCON

03 70 63 21 79

Territoire

Franche-Comté

Affiliation

Centre hospitalier régional universitaire de Besançon (CHRU Besançon)

Recherche

Expertises :
- Recherche:Epidémiologie
- Plateforme:Epidémiologie

Projets

Cohorte prospective multicentrique d'aidants informels en Bourgogne et Franche-Comté. Cohorte ICE (Informal Carers of Elderly) (Cohorte ICE)

2013 - Porteurs du projet : Pr BONNETAIN Franck , Pr LEJEUNE Catherine , Pr NERICH Virginie - Partenaires : Pr BONNET Magalie , Pr CORMIER Luc , Dr DABAKUYO-YONLI Sandrine , Pr DION Michèle , Dr FAGNONI Philippe , Dr QUIPOURT Valérie , Mme POZET Astrid , Dr MONNIER Florent , Mme BAILLY Vanessa

Publications

Predictive and prognostic factors of efficacy of third-line chemotherapy in patients with unresectable pancreatic cancer: a cohort-based study.

Evrard C, Pelras A, Rivet S, Bachet JB, Dubreuil O, Pointet AL, Taieb J, Lahlou W, Portal A, Lepère C, Lecomte T, Chautard R, Williet N, Phelip JM, Coutzac C, Soularue E, Marthey L, Abdallah R, Thirot Bidault A, Artru P, Desrame J, Le Roy B, Jary M, Hammel P, Trouilloud I, Lourenco N, Hautefeuille V, Dahan L, Pernot S, Béchade D, Pozet A, Bonnetain F, Locher C, Dréanic J, Coriat R, Tchoundjeu B, Foucher Y, Tougeron D

Oncologist. 2025 06 4;30(6):

Intraoperative indocyanine green fluorescence angiography in colorectal surgery to prevent anastomotic leakage: A single-blind phase III multicentre randomized controlled trial (FLUOCOL-01/FRENCH 21/GRECCAR 19 intergroup trial).

Pretalli JB, Vernerey D, Evrard P, Pozet A, Clairet AL, Benoist S, Karoui M, Cotte E, Heyd B, Lakkis Z,

Colorectal Dis. 2025 05;27(5):e70119

Health-state utility values and their time to deterioration in informal caregivers of older patients with chronic diseases.

Pozet A, Falcoz A, Roller C, Jai T, Meurisse A, Nerich V

Front Public Health. 2025 04 30;13:1531608

Stemless Reverse Shoulder Arthroplasty Grants Satisfactory Clinical Scores at Minimum 5 Year Follow-up: Comparative Study.

Quemener A, Dabert A, Rochet S, Antoine A, Pozet A, Nourissat G, Antoni M, Harris H, Agu C, van Rooij F, Obert L

J Shoulder Elb Arthroplast. 2024 10 17;8:24715492241291315

Distal radius fractures after 75 years of age: are six-month functional and radiological outcomes better with plate fixation than with conservative treatment?

Ballet S, Guerzider-Regas I, Aouzal Z, Pozet A, Quemener-Tanguy A, Koehly A, Obert L, Loisel F

Orthop Traumatol Surg Res. 2024 07 24;:103959

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.

Pozet A, Darnis S, Bonnet M, Meurisse A, Dabakuyo-Yonli TS, Lejeune C, Fagnoni P, Gaimard M, Manckoundia P, Quibel C, Marchand M, Anota A, Nerich V

Int J Public Health. 2023 08 30;68:1605459

Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.

Allart M, Leroy F, Kim S, Sefrioui D, Nayeri M, Zaanan A, Rousseau B, Ben Abdelghani M, de la Fouchardière C, Cacheux W, Legros R, Louafi S, Tougeron D, Bouché O, Fares N, Roquin G, Bignon AL, Maillet M, Pozet A, Hautefeuille V,

Dig Liver Dis. 2021 Aug 9;:

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review.

Anota A, Pozet A, Lemasson H, Cotté FE, Falcoz A, Eberst G, Mouillet G, Guerzider S, Charton É, Westeel V

Qual Life Res. 2021 Jul 20;:

Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.

Lapeyre-Prost A, Perkins G, Vallee M, Pozet A, Tougeron D, Maillet M, Locher C, Dreanic J, Legoux JL, Lièvre A, Lecaille C, Sabate JM, Mary F, Bonnetain F, Jaulmes-Bouillot H, Behal F, Landi B, Taieb J

Clin Res Hepatol Gastroenterol. 2021 Apr 27;:101709

Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.

Mouillet G, Falcoz A, Fritzsch J, Almotlak H, Jacoulet P, Pivot X, Villanueva C, Mansi L, Kim S, Curtit E, Meneveau N, Adotevi O, Jary M, Eberst G, Vienot A, Calcagno F, Pozet A, Djoumakh O, Borg C, Westeel V, Anota A, Paget-Bailly S

Qual Life Res. 2021 Jan 2;:

[Attachment and caregivers' life course facing cancer].

Bonnet M, Vadam F, Belot RA, Quibel C, Pozet A, Nerich V

Bull Cancer. 2020 Oct 6;:

GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer.

Selle F, Heudel PE, Hardy-Bessard AC, Pozet A, Meunier J, Gladieff L, Lotz JP, Provansal M, Augereau P, Berton D, Bonichon-Lamichhane N, Orfeuvre H, Pautier P, Kalbacher E, Tazi Y, Spaeth D

Anticancer Res.. 2020 Jul;40(7):3939-3945

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study.

Pointet AL, Tougeron D, Pernot S, Pozet A, Béchade D, Trouilloud I, Lourenco N, Hautefeuille V, Locher C, Williet N, Desrame J, Artru P, Soularue E, Le Roy B, Taieb J

Clin Res Hepatol Gastroenterol. 2019 Oct 10;:

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol.

Mouillet G, Fritzsch J, Paget-Bailly S, Pozet A, Es-Saad I, Meurisse A, Vernerey D, Mouyabi K, Berthod D, Bonnetain F, Anota A, Thiery-Vuillemin A

Health Qual Life Outcomes. 2019 Feb 4;17(1):25

Folfirinox gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study.

Williet N, Saint A, Pointet AL, Tougeron D, Pernot S, Pozet A, Bechade D, Trouilloud I, Lourenco N, Hautefeuille V, Locher C, Desrame J, Artru P, Thirot Bidault A, Le Roy B, Pezet D, Phelip JM, Taieb J

Therap Adv Gastroenterol. 2019 ;12:1756284819878660

Metastatic colorectal signet-ring cell carcinoma: Clinical, histological and molecular description from an AGEO French multicenter retrospective cohort.

Allart-Sava M, Le Roy F, Kim S, Sefrioui D, Mariette C, Zaanan A, Rousseau BJ, Ben Abdelghani M, De La Fouchardière C, Cacheux W, Legros R, Louafi S, Tougeron D, Fares N, Roquin G, Bignon Bretagne AL, Maillet M, Tchoundjeu B, Pozet A, Hautefeuille V

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii186

Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study.

Zaanan A, Palle J, Soularue E, Leroy F, Louafi S, Tougeron D, Manfredi S, Artru P, Pozet A, Taieb J

Target Oncol. 2018 Feb;13(1):107-112

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Palle J, Tougeron D, Pozet A, Soularue E, Artru P, Leroy F, Dubreuil O, Sarabi M, Williet N, Manfredi S, Martin-Babau J, Rebischung C, Abdelghani MB, Evesque L, Dreanic J, Hautefeuille V, Louafi S, Sefrioui D, Savinelli F, Mabro M, Rousseau B, Lecaille C, Bouché O, Louvet C, Lecomte T, Bonnetain F, Taieb J, Zaanan A

Oncotarget. 2017 Nov 24;8(60):101383-101393

Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty.

Vernerey D, Anota A, Vandel P, Paget-Bailly S, Dion M, Bailly V, Bonin M, Pozet A, Foubert A, Benetkiewicz M, Mankoundia P, Bonnetain F

BMC Geriatr. 2016 Nov;16(1):187

Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.

Brieau B, Auzolle C, Pozet A, Tougeron D, Bouché O, Soibinet P, Coriat R, Prieux C, Lecomte T, Goujon G, Marthey L, Rougier P, Bonnetain F, Ducreux M, Taieb J, Zaanan A

Dig Liver Dis. 2016 Apr;48(4):441-5

Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.

Lledo G, Huguet F, Chibaudel B, Di Fiore F, Mineur L, Galais MP, Artru P, Blondin V, Dupuis O, Abdiche MS, Jovenin N, Pozet A, Bonnetain F, Attia M, Dahan L, de Gramont A

Eur. J. Cancer. 2016 Mar;56:115-121

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study.

Caubet M, Dobi E, Pozet A, Almotlak H, Montcuquet P, Maurina T, Mouillet G, N'guyen T, Stein U, Thiery-Vuillemin A, Fiteni F

Mol Clin Oncol. 2015 Nov;3(6):1208-1212

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.

Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet JB, Vaillant JC, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J

Eur J Surg Oncol. 2015 Apr;41(4):520-6